Abstract
The primary goal of radioiodine therapy is to achieve the ablation of residual thyroid cancer tissue following total thyroidectomy in the treatment of thyroid cancer. Due to its ease of application, the fixed-dose method is the most commonly used approach in clinical practice. In patient-specific dosimetry, it is essential to understand the dose-response relationship prior to treatment to determine the minimum effective and maximum safe absorbed doses, tumor radiation response, and healthy tissue toxicity for each patient. The radioiodine dose required for residual tissue ablation is known to be 300 Gy. During dosimetry procedures, the amount of iodine-131 activity necessary to deliver this dose is calculated.
Keywords: Remnant tissue dosimetry, radioiodine therapy, dosimetry
References
Jameson JL, De Groot JL. Endocrinology adult and pediatric. In: Pacini F, Marchisotta S, De Groot JL. Thyroid neoplasia. Saunders Elsevier, 6th edition, Philadelphia. 2010:1668-1701.
Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association manage- ment guidelines for patients with thyroid no- dules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
Machens A, Ukkat J, Hauptmann S, Dralle H. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis. Arch Surg. 2007;142:289-293; discussion 294.
Nükleer Düzenleme Kurumu. Erişim linki: https://www.ndk.org.tr/
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1-133.
Maxon HR, Thomas SR, Hertzberg VS, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med. 1983;309:937-941.
Benua RS, Cicale NR, Sonenberg M, Rawson RW. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgenol Radium Ther Nucl Med. 1962;87:171-182.
Schlafke-Stelson AT, Watson EE, Cloutier RJ. A history of medical internal dosimetry. Health Phys. 1995;69:766-782.
Siegel JA, Stabin MG. Absorbed fractions for electrons and beta particles in spheres of various sizes. J Nucl Med. 1994;35:152-156.
The radiation dose assessment resource. Available link: https://www.doseinfo-radar.com/
